IP Library Granted Patent US 11,339,399
Granted Patent B2
US 11,339,399 · App. 14/986,492 · Granted May 24, 2022

Compositions and methods for high efficiency in vivo genome editing

Inventors: John Verruto (San Diego, CA); Eric Moellering (San Diego, CA)
Assignee: Viridos, Inc.
C12N15/8213C12N9/1241C12N9/22C12N15/8209C12N15/8216C12N15/85C12N15/90C12N15/905C12N15/907C12Y207/07
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,339,399
App. No.
14/986,492
Granted
May 24, 2022
Kind
B2
Abstract

The present invention provides cell lines for high efficiency genome editing using cas/CRISPR systems, methods of generating such cells lines, and methods of generating mutations in the genome of an organism using such cell lines.

Claims (29)

1. A fully penetrant RNA-guided endonuclease-expressing Nannochloropsis or Parachlorella algal strain comprising, a nucleic acid sequence encoding a heterologous RNA-guided endonuclease;

a nucleic acid sequence encoding a nuclear localization signal linked to the nucleic acid sequence encoding the heterologous RNA-guided endonuclease; and

a nucleic acid sequence encoding a fluorescent detectable protein and;

wherein the fully penetrant algal strain exhibits culture-wide expression of the heterologous RNA-guided endonuclease, as indicated by a single fluorescent peak in a flow cytometry histogram.

2. A fully penetrant RNA-guided endonuclease-expressing algal strain according to claim 1 , wherein the RNA-guided endonuclease is a Cas nuclease.

3. A fully penetrant RNA-guided endonuclease-expressing algal strain according to claim 2 , wherein the RNA-guided endonuclease is a Cas9, Cpf1, C2c1, C2c2, or C2c3 nuclease.

4. A fully penetrant RNA-guided endonuclease-expressing algal strain according to claim 1 , wherein the strain has a targeted mutation rate of at least 50% using a gRNA and donor fragment that comprises a selectable marker.

5. A fully penetrant RNA-guided endonuclease-expressing algal strain according to claim 1 , wherein the fully penetrant RNA-guided endonuclease-expressing algal strain does not include a fluorescent protein gene.

6. A fully penetrant RNA-guided endonuclease-expressing algal strain according to claim 1 , wherein the RNA-guided endonuclease-expressing algal strain further comprises an exogenous gene encoding a site-specific recombinase.

7. A fully penetrant RNA-guided endonuclease-expressing algal strain according to claim 6 , wherein the site-specific recombinase is cre, frt, or dre.

8. A fully penetrant RNA-guided endonuclease-expressing algal strain according to claim 7 , wherein the exogenous gene encoding a site-specific recombinase is operably linked to an inducible promoter.

9. A method of altering the genome of a Nannochloropsis or Parachlorella algal cell, wherein the method comprises:

introducing at least one guide RNA or at least one construct for expressing at least one guide RNA into a Nannochloropsis or Parachlorella algal strain according to claim 1 , wherein the guide RNA targets a site in the genome of the cell; and

screening cells transformed with the guide RNA for alteration of the targeted site in the genome.

10. A method according to claim 9 , wherein the at least one guide RNA is a chimeric guide RNA.

11. A method according to claim 9 , wherein the at least one guide RNA is a crRNA.

12. A method according to claim 9 , wherein the fully penetrant RNA-guided endonuclease-expressing algal strain further comprises a construct encoding a tracrRNA.

13. A method according to claim 9 , wherein the method further comprises introducing a tracrRNA into the fully penetrant RNA-guided endonuclease-expressing algal strain.

14. A method according to claim 9 , wherein the method further comprises transforming a donor DNA into the fully penetrant RNA-guided endonuclease-expressing algal strain.

15. The fully penetrant RNA-guided endonuclease-expressing algal strain of claim 1 wherein the heterologous RNA-guided endonuclease is Cas9 and the fluorescent detectable protein is selected from the group consisting of: a green fluorescent protein, a yellow fluorescent protein, an orange fluorescent protein, a red fluorescent protein, and a cyan fluorescent protein.

16. The fully penetrant RNA-guided endonuclease-expressing algal strain of claim 15 wherein the fluorescent detectable protein is green fluorescent protein.

17. The fully penetrant RNA-guided endonuclease-expressing algal strain of claim 1 wherein the strain has a genome editing efficiency of at least 50%.

18. The fully penetrant RNA-guided endonuclease-expressing algal strain of claim 17 wherein the strain has a genome editing efficiency of at least 80%.

19. The fully penetrant RNA-guided endonuclease-expressing algal strain of claim 1 wherein the algal strain is of the genus Nannochloropsis.

20. The fully penetrant RNA-guided endonuclease-expressing algal strain of claim 1 is of the genus Parachlorella.

21. The method of claim 9 wherein the algal cell is of the genus Nannochloropsis.

22. The method of claim 9 wherein the algal cell is of the genus Parachlorella.

23. The fully penetrant RNA-guided endonuclease-expressing algal strain of claim further comprising a nucleic acid sequence encoding a selectable marker.

24. The fully penetrant RNA-guided endonuclease-expressing algal strain of claim 1 wherein the fluorescent detectable protein is green fluorescent protein.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2026
From: VIRIDOS, INC.
To: PHYKION INC.
Reel/Frame 073421/0601 →
SECURITY INTEREST Recorded Sep 13, 2024
From: VIRIDOS, INC.
To: BREAKTHROUGH ENERGY VENTURES II, L.P.
Reel/Frame 068589/0049 →
CHANGE OF NAME Recorded Apr 7, 2022
From: SYNTHETIC GENOMICS, INC.
To: VIRIDOS, INC.
Reel/Frame 059631/0684 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2020
From: OXFORD FINANCE LLC
To: SYNTHETIC GENOMICS, INC.; GENOVIA BIO, LLC; GREEN RESOURCES, LLC; SGI-DNA, INC.; SYNTHETIC GENOMICS VACCINES, INC.
Reel/Frame 054372/0822 →
SECURITY INTEREST Recorded Mar 20, 2019
From: SYNTHETIC GENOMICS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 048655/0406 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2016
From: VERRUTO, JOHN H.; MOELLERING, ERIC R.
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 037720/0622 →
Continuity (2)
Provisional Application 62099014 · Dec 31, 2014
Related Publication 20170073695A1 · Mar 16, 2017